Hàn Quốc cấp phép khẩn cấp thuốc molnupiravir điều trị COVID-19

Thế giới

Trong nỗ lực giảm ca bệnh nặng và tử vong do COVID-19, cơ quan an toàn dược phẩm của Hàn Quốc ngày 23/3 đã cấp phép khẩn cấp thuốc molnupiravir của hãng Merck & Co Inc để điều trị cho người trưởng thành mắc COVID-19.

Email Print twitter facebook

21:04 23/03/2022 GMT+7

Đọc nhiều

{publishtime}

{title}
{publishtime}
{title}
{lead}

{title}

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

Theo Yonhap

{name} - {time}

Trả lời

{body}

{name} - {time}

{body}